Skip to main content
Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.4445
-0.0011 (-0.25%)
At close: Nov 11, 2026, 4:00 PM EST
0.4599
+0.0154 (3.46%)
Pre-market: Nov 12, 2026, 8:14 AM EST

Aprea Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
00.291.50.58--
Revenue Growth
-99.32%-80.98%157.63%---
Gross Profit
-7.04-6.76-7.86-7.04-16.4-23.9
Operating Income
-15.28-13.23-14.32-15.47-37.37-37.45
Net Income
-14.14-12.6-12.96-14.29-112.66-37.13
Earnings Per Share
-0.44-1.93-2.35-3.95-67.99-34.88
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
37.8514.622.8521.6128.7953.08
Total Debt
-----0.19
Net Cash (Debt)
37.8514.622.8521.6128.7952.89
Net Cash Growth
175.89%-36.11%5.75%-24.94%-45.57%-
Net Cash Per Share
1.162.234.155.9717.3749.69

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-12.72-12.89-13.56-12.18-25.01-37.69
Capital Expenditures
-0.02--0.02-0.09--
Free Cash Flow
-12.74-12.89-13.57-12.27-25.01-37.69
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
-457872.76%-4631.12%-953.00%-2652.80%--
Pretax Margin
-423878.66%-4409.16%-862.43%-2449.59%--
Profit Margin
-423878.66%-4409.16%-862.43%-2449.59%--
FCF Margin
-381769.10%-4512.35%-903.26%-2103.92%--

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1890.3120.8811.9030.11--